{
    "SPADE_N_13728": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13728",
            "Peptide Name": "BMP32 (natural AMPs; Bacteriocin, Gram-positive bacteria, prokaryotes, UCLL1; recombinant form BMP32r; BBMm)",
            "Source": "culture supernatant,Lactobacillus crustorumMN047",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "MTVTDPRSPLTTWIFFCSKKTTPPLKGAVVMPNSGLSRHLHYLRLSSRCLSNSRNTPTSSGAMIA",
            "Sequence Length": 65,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "C311H511N88O90S5",
            "Mass": 7121.23,
            "PI": 10.96,
            "Hydrophobicity": -0.17,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Yi L, Luo L, LÃ¼ X.2018",
                    "Reference": "Front Microbiol. 2018 Jul 13;9:1567. doi: 10.3389/fmicb.2018.01567PubMed",
                    "Title": "Efficient Exploitation of Multiple Novel Bacteriocins by Combination of Complete Genome and Peptidome."
                }
            ],
            "Frequent Amino Acids": "STL",
            "Absent Amino Acids": "EOQU",
            "Basic Residues": 10,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 28,
            "Polar Residues": 40,
            "Positive Residues": 10,
            "Negative Residues": 1,
            "Net Charge": 9,
            "Target Organism": "Diffusion zone assay: active against Gram+ S. aureus ATCC 29213, 25923 (19.0-19.7 mm), E. faecalis ATCC 29212 (15.2 mm), L. monocytogenes CMCC 54004 (16.7 mm),  Gram- E. coli ATCC 25922 (17.4 mm), Salmonella CMCC 50071 (20.6 mm), C. sakazakii ATCC 29544 (17.6 mm), also active against antibiotic-resistant C. sakazakii (18.5-21.2 mm) and Salmonella 557D (18.6 mm). The recombinant peptide (BMP32r) is active against Gram- E. coli ATCC 25922 (MIC 9.2 ug/ml), C. sakazakii ATCC 29544 (MIC 18.4 ug/ml), Salmonella SH11G0461 (MIC 27.6 ug/ml), C. sakazakii (MIC 18.4-27.6 ug/ml), Gram+ E. faecalis ATCC 29212 (MIC 18.4 ug/ml), S. aureus ATCC 25923 (MIC 18.4-36.8 ug/ml) inclusing antibiotic-resistant strains. It permeabilized the membranes of E. coli and S. aureus. Animal model:mouse: BMP32r reduced S. aureus load in the wound and promoted wound healing as well (Qiao Z. et al., 2020).",
            "Similar Sequences": []
        }
    }
}